Skip to main content
Fig. 4 | Thrombosis Journal

Fig. 4

From: A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time

Fig. 4

Effect of (p-BthTX-I)2 K on platelet aggregation. The compound provoked a decline in platelet aggregation with arachidonic acid, collagen, and ADP (A-C) after incubation with 434.8 and 608.7 µg (arachidonic acid) or 32.6 and 65.2 µg (collagen and ADP). Statistical analysis by comparing the groups with Student t-test with p < 0.001. Curves refer to platelet aggregation assays demonstrating the dose-dependent effect of the peptide on the aggregation of human platelets

Back to article page